Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Case Report
Case series
Editorial
Erratum
Guest Editorial
Letter to Editor
Letter to the Editor
Media and News
Medial Education
Medical Education
Obituary
Opinion Article
Original Article
Review Article
Short Communication
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Case Report
Case series
Editorial
Erratum
Guest Editorial
Letter to Editor
Letter to the Editor
Media and News
Medial Education
Medical Education
Obituary
Opinion Article
Original Article
Review Article
Short Communication
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Case Report
Case series
Editorial
Erratum
Guest Editorial
Letter to Editor
Letter to the Editor
Media and News
Medial Education
Medical Education
Obituary
Opinion Article
Original Article
Review Article
Short Communication
View/Download PDF

Translate this page into:

Original Article
ARTICLE IN PRESS
doi:
10.25259/IJPP_156_2025

Exploration of analytical tools for heart rate variability analysis: Insights into differences

Department of Physiology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.

*Corresponding author: Shival Srivastav, Department of Physiology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India. drshival@gmail.com

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Shobhawat M, Srivastav S, Shukla R, Bhagat O. Exploration of analytical tools for heart rate variability analysis: Insights into differences. Indian J Physiol Pharmacol. doi: 10.25259/IJPP_156_2025

Abstract

Objectives:

Heart rate variability (HRV) provides insight into autonomic modulation of the heart rate. HRV indices – classified as time domain, frequency domain and non-linear indices – are computed using software tools. While the calculation of time domain indices is relatively straightforward, there exists heterogeneity in the methodology of spectral analysis of HRV parameters across different platforms. We compared HRV indices derived from electrocardiogram (ECG) data recorded in healthy adults using Kubios (‘K’), LabChart (‘L’) and Nevrokard (‘N’) software solutions.

Materials and Methods:

A single observer analysed HRV indices from 5-min Lead II ECG epochs using ‘K’, ‘L’ and ‘N’ software. Time domain and frequency domain indices were computed and compared. Bias between the software was assessed using Bland–Altman analysis by choosing ‘N’ as the reference method. Mean bias and limits of agreement were compared.

Results:

Data of 53 healthy adults (40 males, 13 females; mean age = 29.89 ± 6.94 years) were analysed. Time domain indices, while exhibiting statistically significant differences, had slight differences between ‘K’, ‘L’ and ‘N’. Median frequency domain indices derived from ‘K’, ‘L’ and ‘N’ demonstrated statistically significant differences, especially low frequency (LF), high frequency (HF) and normalised powers of LF and HF. Furthermore, they demonstrated reasonable bias between tools.

Conclusion:

HRV indices, especially frequency domain indices, may be affected by the analytical methodology adopted by the software tool. While we cannot establish superiority of one software over another, we recommend detailed documentation of analytical approach of HRV data in scientific literature. In addition, comparison of HRV indices using different analytical tools merits a cautious approach.

Keywords

Autonomic nervous system
Data analysis
Fourier analysis
Heart rate variability
Software

INTRODUCTION

Heart rate variability (HRV) provides insight into the physiological underpinnings of the modulation of the heart. The autonomic nervous system is amongst the major influencers of perturbations in resting heart rate (HR). In addition, respiration, thermoregulation and the neuroendocrine system also have a bearing on it.[1,2] The variability of the seemingly chaotic HR signal can be computed using multiple mathematical indices that come under the common umbrella of HRV. These indices are categorised as time domain, frequency domain and nonlinear indices. Recommendations for standardisation and computation of these indices were described in the seminal Task Force guidelines, described by the European Society of Cardiology in 1996.[3]

Analysis of 5-min-long epochs of inter-beat interval data, known as ‘short-term’ HRV, is commonly used in the clinical physiology laboratory for evaluation of cardiac autonomic tone. Furthermore, short-term HRV values have been widely reported in published literature. There have been multiple studies globally in different populations and age groups with an objective to define normative cut-off values for different populations.[4-8] In addition, multiple studies have been undertaken in our country to describe normative data for different geographical regions.[9-13] Such data are particularly relevant for the purpose of defining age- and gender-specific cut-offs for different populations to strengthen the use of HRV as a tool for autonomic neuropathy screening.

Common metrics derived from time domain and frequency domain analysis of HRV have been defined to describe the variability of inter-beat interval data. Time domain indices include standard deviation of normal-to-normal intervals (SDNN), root mean square of successive differences (RMSSD) of normal-to-normal intervals, standard deviation (SD) of successive differences, number of normal-to-normal intervals varying by more than 50 ms from preceding intervals (NN50) and their percentage (pNN50%). Frequency domain metrics are derived from Fast Fourier Transform (FFT)/Autoregressive analysis of the inter-beat interval time series and include total power (TP), power in low-frequency (LF) band and high-frequency (HF) band and LF/HF ratio. In addition, frequency domain indices are expressed as normalised power in LF band (LF-nu) and HF band (HF-nu) to negate the effect of very low-frequency (VLF) component, which is primarily respiration driven.

A careful scrutiny of HRV literature reveals a plethora of software solutions for analytical purposes. Popular software tools for HRV measurement include Nevrokard,[14,15] Kubios[16] and LabChart.[17,18] We propose that time domain indices (SDNN, RMSSD, nn50 and pNN50) employ simple mathematical calculations and therefore should be similar irrespective of the software used for analysis. However, frequency domain parameters involve resampling of data followed by FFT using different windowing and data padding techniques. Therefore, while time domain indices may be similar across software tools, frequency domain indices should be different and dependent on the analytical tool. However, we observed a paucity of literature comparing popular HRV analysis tools. Therefore, we undertook the present work to compare HRV indices derived using popular analytical tools and explore the differences, if any.

MATERIALS AND METHODS

The protocol was approved by the Institutional Ethics Committee of our institution. Apparently healthy subjects of either sex were recruited. The sample size was calculated using HRV values in the Indian population in a previous study by Rajalakshmi et al.[19] wherein three HRV software were compared. We assumed a power of 80% and Type I error to be 5% and used a comparison of means approach to calculate the sample size. The sample size obtained was 30.

Written informed consent was obtained after a detailed explanation of the study protocol. Participants were requested to report to the autonomic function laboratory of the department of physiology of our institute, 2 h after a light meal. Abstinence from tea, coffee and nicotine was ensured on the morning of the test. All recordings were done in the forenoon between 9 am and 1 pm. Female subjects were requested to report to the laboratory between days 2 and 6 of the cycle. All study participants were requested to void their bladders and were provided a supine rest of 10 min before commencement of data acquisition.

Disposable adhesive ECG electrodes were applied to the skin after thorough cleaning of the application sites with alcohol-based swabs. The electrodes were connected to a wireless BioNomandix wireless module of Biopac MP150 (Biopac Inc., USA) system. Lead II ECG data were acquired in the supine position for 6 min. The subjects were requested to breathe normally and avoid movement to prevent motion artefacts. The investigator ensured that the data acquired was free from artefacts. Data were acquired using Acqknowledge software version 4.4.0 (Biopac Inc., USA) and stored for offline analysis.

We exported a clean noise and artefact-free data segment of 5 min length as Acqknowledge 3 (*.acq3) format for the purpose of analysis for every study subject. We utilised Nevrokard aHRV version 13.2.2 (Nevrokard Kiauta, Slovenia), LabChart Pro version 8.1.30 (AD Instruments, Australia) and Kubios Scientific Lite version 4.1.2.1 (Kubios Oy, Finland) for HRV analysis. These software tools are referred to by acronyms ‘N’, ‘L’ and ‘K’ henceforth. ‘N’ and ‘L’ can directly import ‘acq3’ files for HRV analysis. However, the free version of ‘K’ used in the study can only import American Standard Code for Information Interchange (ASCII)/text files containing RR intervals. Therefore, RR intervals were extracted from the entire length of ECG data using ‘L’ software and imported into ‘K’ for HRV analysis. All the data segments analysed were exactly 5 min long and were performed by a single observer to prevent inter-observer variability. Visual inspection of the data was done to ensure that all peaks were selected for analysis.

Time domain indices – SDNN, RMSSD and pNN50 – were compared for all three software tools. Similarly, frequency domain indices – TP, LF power, HF power, Normalised LF and HF power (LF-nu and HF-nu respectively) – were compared for the three software. We would like to emphasise that the individual tools provide a wide array of HRV indices, in addition to the aforementioned time domain and frequency domain indices. However, we chose only those indices common to the three software. Furthermore, these metrics are widely reported in HRV research.

Postscripts ‘_K’, ‘_L’ and ‘_N’ were added to the metrics to denote analysis done using Kubios Scientific Lite version 4.1.2.1, LabChart Pro version 8.1.30 and Nevrokard aHRV version 13.2.2 software, respectively.

Values were described as Mean ± SD or Median (interquartile range) based on the distribution, which was assessed using Shapiro–Wilk test. Repeated measures analysis of variance or Friedman’s test with appropriate post hoc tests was used for comparison of the parameters, based on the distribution of parameters. Bland–Altman Analysis was used to evaluate the agreement between the methods, employing a ‘Difference versus Average’ approach. We arbitrarily chose Nevrokard software as the reference, since we observed that it was older than the other tools. In addition, the program has been used in multiple peer-reviewed publications. A P < 0.05 was considered statistically significant. MedCalc Statistical Software version 23.1.2 (MedCalc Software Ltd, Ostend, Belgium; https://www.medcalc.org; 2025)[20] was used for statistical analysis.

RESULTS

We recruited 53 healthy adults (40 males and 13 females, mean age = 29.89 ± 6.94 years) in the present study. Mean height, weight and BMI of the subjects were 167.74 ± 9.37 cm, 68.33 ± 15.08 kg and 24.23 ± 4.68 kg/m2, respectively.

While there was statistically significant difference between time domain indices (SDNN, RMSSD and pNN50, P = 0.00052, 0.0066 and 0.021 respectively), median values were very close to each other [Figure 1]. In frequency domain indices, there was no significant difference between TP and LF power (P = 0.121 and 0.090, respectively). However, HF power was significantly different between the software tools (P < 0.00001), with median values exhibiting an increasing trend from HF_K, HF_L and HF_N indices. The values appeared to be within normal range. We also observed statistically significant difference between LF-nu and HFnu indices derived using the software (P < 0.0001 and 0.004 respectively, [Figure 2]).

Comparison of time domain parameters calculated using different software tools. There was a significant difference between (a) standard deviation of normal-to-normal intervals (SDNN), (b) root mean square of successive differences (RMSSD) and (c) percentage of RR intervals varying by more than 50 ms than preceding intervals (pNN50)estimated using the three tools (P = 0.0005, 0.0066 and 0.021 respectively, Friedman’s test with Dunn’s post hoc test). Parameters represented as box and whisker plots. Individual data points also depicted. ‘_K’, ‘_L’ and ‘_N’ represent parameters derived using Kubios™, LabChart™ and Nevrokard™ software respectively. SDNN: Standard deviation of normal to normal intervals, RMSSD: Root mean square of successive differences, pNN50: percentage of RR intervals varying by more than 50 ms than preceeding intervals. P values from intergroup comparisons are mentioned in-line.
Figure 1:
Comparison of time domain parameters calculated using different software tools. There was a significant difference between (a) standard deviation of normal-to-normal intervals (SDNN), (b) root mean square of successive differences (RMSSD) and (c) percentage of RR intervals varying by more than 50 ms than preceding intervals (pNN50)estimated using the three tools (P = 0.0005, 0.0066 and 0.021 respectively, Friedman’s test with Dunn’s post hoc test). Parameters represented as box and whisker plots. Individual data points also depicted. ‘_K’, ‘_L’ and ‘_N’ represent parameters derived using Kubios, LabChart and Nevrokard software respectively. SDNN: Standard deviation of normal to normal intervals, RMSSD: Root mean square of successive differences, pNN50: percentage of RR intervals varying by more than 50 ms than preceeding intervals. P values from intergroup comparisons are mentioned in-line.
Comparison of frequency domain parameters calculated using different software tools. (a) Total Power, (b) and Power in low frequency band (LF Power) were comparable between the software (P = 0.121 and 0.0902, respectively). There was a significant difference between (c) power in High frequency band (HF Power), (d), normalized power in Low frequency band (LFnu), (e) and normalized power in High frequency band (HF-nu) (P < 0.00001, <0.0001 and 0.0040, respectively, Friedman’s test with Dunn’s post hoc test). Parameters represented as box and whisker plots. Individual data points are also depicted. ‘_K’, ‘_L’ and ‘_N’ represent parameters derived using Kubios™, LabChart™ and Nevrokard™ software, respectively. p values from intergroup comparisons are mentioned in-line.
Figure 2:
Comparison of frequency domain parameters calculated using different software tools. (a) Total Power, (b) and Power in low frequency band (LF Power) were comparable between the software (P = 0.121 and 0.0902, respectively). There was a significant difference between (c) power in High frequency band (HF Power), (d), normalized power in Low frequency band (LFnu), (e) and normalized power in High frequency band (HF-nu) (P < 0.00001, <0.0001 and 0.0040, respectively, Friedman’s test with Dunn’s post hoc test). Parameters represented as box and whisker plots. Individual data points are also depicted. ‘_K’, ‘_L’ and ‘_N’ represent parameters derived using Kubios, LabChart and Nevrokard software, respectively. p values from intergroup comparisons are mentioned in-line.

Bias between the software tools and limits of agreement were analysed using Bland–Altman analysis. Bland–Altman analysis compares the differences between an established and a test method and provides information regarding bias between the parameters. The values are expressed as difference versus arithmetic mean of methods,[21] difference versus geometric mean or difference versus sample rank-based approaches. As discussed previously, we chose Nevrokard as the reference tool since we found it to be the oldest amongst the three being evaluated. We performed the analysis of difference versus average of the parameter shown in the two tools under comparison. We observed that SDNN was underestimated by ‘K’ and ‘L’ software as compared to NK (Mean difference = −0.13 and −0.20, respectively). Similar trend was observed in RMSSD and pNN50 values (Mean difference = −0.4 and −0.6 and −0.4 and −0.3 respectively, [Figure 3]).

Comparison of bias between Kubios™ and LabChart™ software versus Nevrokard™ software using Bland–Altman analysis: Time domain indices. Comparison of bias between time domain indices standard deviation of normal-to-normal intervals (SDNN), root mean square of successive differences (RMSSD) and percentage of RR intervals varying by more than 50 ms than preceding intervals (pNN50) calculated using Kubios™ (_K) and LabChart™ (_L) software versus Nevrokard™ (_N) software for heart rate variability analysis. The central solid line represents mean bias, whereas the two flanking dotted lines represent limits of agreement. Whiskers on the limits of agreement depict 95% confidence interval. The dotted line at 0 mark represents the line of equality. SDNN: Standard deviation of normal to normal intervals, RMSSD: Root mean square of successive differences, pNN50: percentage of RR intervals varying by more than 50 ms than preceeding intervals
Figure 3:
Comparison of bias between Kubios and LabChart software versus Nevrokard software using Bland–Altman analysis: Time domain indices. Comparison of bias between time domain indices standard deviation of normal-to-normal intervals (SDNN), root mean square of successive differences (RMSSD) and percentage of RR intervals varying by more than 50 ms than preceding intervals (pNN50) calculated using Kubios (_K) and LabChart (_L) software versus Nevrokard (_N) software for heart rate variability analysis. The central solid line represents mean bias, whereas the two flanking dotted lines represent limits of agreement. Whiskers on the limits of agreement depict 95% confidence interval. The dotted line at 0 mark represents the line of equality. SDNN: Standard deviation of normal to normal intervals, RMSSD: Root mean square of successive differences, pNN50: percentage of RR intervals varying by more than 50 ms than preceeding intervals

Amongst frequency domain indices, ‘K’ and ‘L’ overestimated TP (Mean difference = 77.2 and 205.7 respectively). Both ‘K’ and ‘L’ underestimated LF-power (Mean difference = −32.8 and −2.9 respectively) and HF power (Mean difference = −134.8 and −79.7 respectively). Normalised powers of LF and HF (LF-nu and HF-nu) were overestimated by ‘K’ and ‘L’ software when compared with ‘N’ (mean difference = 5.5 and 4.4 and 2.2 and 0.1, respectively). The mean differences and limits of agreement for the aforementioned parameters are shown in Figures 4 and 5, respectively.

Comparison of bias between Kubios™ and LabChart™ software versus Nevrokard™ software using Bland–Altman analysis: Frequency domain indices. Comparison of bias between frequency domain indices (Total power, Power in low frequency band (LF) and high frequency band (HF)) using Kubios™ (_K) and LabChart™ (_L) software versus Nevrokard™ (_N) software for heart rate variability analysis. The central solid line represents mean bias, whereas the two flanking dotted lines represent limits of agreement. Whiskers on the limits of agreement depict 95% confidence interval. Dotted line at 0 mark represents the line of equality.
Figure 4:
Comparison of bias between Kubios and LabChart software versus Nevrokard software using Bland–Altman analysis: Frequency domain indices. Comparison of bias between frequency domain indices (Total power, Power in low frequency band (LF) and high frequency band (HF)) using Kubios (_K) and LabChart (_L) software versus Nevrokard (_N) software for heart rate variability analysis. The central solid line represents mean bias, whereas the two flanking dotted lines represent limits of agreement. Whiskers on the limits of agreement depict 95% confidence interval. Dotted line at 0 mark represents the line of equality.
Comparison of bias between Kubios™ and LabChart™ software versus Nevrokard™ software using Bland–Altman analysis: Normalised frequency domain indices. Comparison of bias between normalised frequency domain indices (low frequency-nu power and high frequency-nu power) using Kubios™ (_K) and LabChart™ (_L) software versus Nevrokard™ (_N) software for heart rate variability analysis. The central solid line represents mean bias, whereas the two flanking dotted lines represent limits of agreement. Whiskers on the limits of agreement depict 95% confidence interval. Dotted line at 0 mark represents the line of equality. LFNU and HFNU represent normalized powers in low frequency and high frequency bands respectively. SD represents Standard Deviation.
Figure 5:
Comparison of bias between Kubios and LabChart software versus Nevrokard software using Bland–Altman analysis: Normalised frequency domain indices. Comparison of bias between normalised frequency domain indices (low frequency-nu power and high frequency-nu power) using Kubios (_K) and LabChart (_L) software versus Nevrokard (_N) software for heart rate variability analysis. The central solid line represents mean bias, whereas the two flanking dotted lines represent limits of agreement. Whiskers on the limits of agreement depict 95% confidence interval. Dotted line at 0 mark represents the line of equality. LFNU and HFNU represent normalized powers in low frequency and high frequency bands respectively. SD represents Standard Deviation.

DISCUSSION

HRV has emerged as an integral component for the evaluation of autonomic neuropathy in various disorders such as Diabetes mellitus, Heart failure, Myocardial Infarction and Epilepsy.[22-26] It has been shown to serve as a marker of morbidity, mortality and long-term survival in aforementioned disorders. In addition, HRV has found applications in diverse physiological domains such as sports physiology, cognitive physiology and wellness.[27-29] The rise of wearable technology[30,31] has invigorated the interest in HRV measurement from the wrist. Furthermore, an upsurge has been observed in ultra-short HRV metrics involving computation of HRV measures from small segments of inter-beat interval data. The segments typically range from 30 s to 2 min.[32,33]

The ECG signal provides a robust and reliable method for quantification of inter-beat intervals, corresponding to RR intervals in this signal. Pan and Tompkins algorithm is a commonly used QRS detector algorithm used to identify the R waves and compute RR interval data.[34] The algorithms for processing the ECG signal of the different tools evaluated in the present work are built on the same principle. After the extraction of inter-beat interval data, the tools proceed to calculate time and frequency domain indices. While calculation of time domain indices is relatively straightforward, that of frequency domain indices varies according to different tools. FFT involves resampling of data to account for unevenly placed RR intervals, followed by using a windowing function such as Hanning or Hamming.[35] This is followed by calculation of spectral powers in well-established frequency bands described previously, i.e. VLF, LF and HF. The frequency bands are classified based on previously well-established works.[36-39] The commonly defined ranges of power spectral bands are as follows: VLF: 0–0.04 Hz, LF: 0.04–0.15 Hz and HF: 0.15–0.40 Hz.

HRV involves the quantification of the scatter in inter-beat interval data using various metrics. These metrics are clubbed together under time domain and frequency domain indices. Time domain indices include SDNN, RMSSD, NN50 and pNN50. SDNN denotes the SDNNs, while RMSSD denotes the root mean square of the difference between the successive intervals. NN50 is the number of RR intervals varying by more than 50 ms with respect to previous intervals, and pNN50 denotes the percentage of such intervals in the total signal. Frequency domain indices, such as TP, LF-Power and HF-Power, denote the spectral powers in the frequency bands from 0 to 0.04 Hz, 0.04 to 0.15 Hz and 0.15 to 0.4 Hz, respectively. These spectral powers are derived from FFT processing of the time series data. The overall variability in the frequency domain is indicated by TP. A detailed summary of these indices has been discussed in various sources previously.[40,41]

In the present work, we observed a significant difference between time and frequency domain indices derived using the three tools [Figures 1 and 2]. While time domain indices (SDNN, RMSSD and pNN50) exhibited significant differences between the median values, Bland–Altman analysis demonstrated very small differences between them. This supports our hypothesis that since time domain indices are relatively straightforward to compute; therefore, they are consistent across various software.

The differences emerge when frequency domain parameters are computed using different tools. In the present work, while TP and Low frequency power were statistically comparable, HF power, HF-nu and LF-nu demonstrated statistically significant differences. There was a bias between the aforementioned indices when comparing ‘K’ and ‘L’ with ‘N’ [Figures 4 and 5].

We attempted to investigate the cause of the differences in the values reported by the tools used for assessment. One of the causes of the difference in values could have been the differences in beat detection in the three tools. Therefore, we compared the beat detection methods of the three tools. ‘L’ uses two parameters for defining a normal beat – RR interval and ‘Complexity’ factor, based on the morphology of the ECG wave. QRS detection is based on an algorithm proposed by Hamilton and Tompkins.[42] The software allows the user to define a range of normal RR intervals and thus ensure selection of maximum peaks. In addition, ‘beat classifier’ view of the software allows changes in the thresholds for RR intervals as well as ‘complexity’ by the user to allow detection of all normal peaks. ‘N’ software allows modifications to baseline at the time of signal import. In addition, the software also allows the user to scroll through the signal and manually insert/removal of missed/spuriously detected R peaks, respectively. Thereafter, the user can opt for ‘deletion’ or ‘digital interpolation’ of the missed peaks. ‘K’ platform allows introduction of ‘beat correction’ algorithm after the signal import, whose threshold may be changed from ‘very low’ to very strong’, enabling optimal detection of all peaks.

In the present work, beat detection was optimal for all the software tools. As discussed previously, the analysis was performed by a single observer to negate inter-observer bias. The observer manually scrolled through the selected ECG data in both ‘L’ and ‘N’ software to ensure that all R peaks were detected. The ECG data segments used in the study were all in Lead II configuration and free from ectopics/artefacts. In addition, the free tier of ‘K’ software used in the present work imported R-R interval data extracted from ‘L’. Therefore, there was little, if any, chance of misdetection of R peaks in ‘K’ software.

‘K’ software has a pre-processing ‘detrending’ algorithm applied to the data at the time of import, switched on by default. [16,43] The ‘detrending’ option automatically removes low-frequency components from the RR interval series. Since it was likely to influence the HRV metrics, we turned it off for all data imports. Furthermore, previous literature has shown that ‘very strong’ threshold correction in ‘K’ software may lead to an unacceptable level of interpolation, and lower levels of threshold correction are recommended.[44-47] Since our ECG data were free from ectopics and artefacts, we did not require application of threshold correction for any study subject.

The probable reason for differences in frequency domain indices was the underlying analytical methodology adopted by the software. The Scientific Lite version of ‘K’ software uses a Welch’s periodogram for FFT, wherein the window width is 300 s with 50% window overlap.[16] ‘L’ software uses a Lomb’s periodogram method to perform spectral analysis. In addition, the default value of the upper cut-off of HF band in ‘L’ was 0.45, which was modified to 0.40 by us in the present work to ensure comparability across tools.

A systematic understanding of the different methodologies adopted by commercially available analytical software that may affect HRV parameters is still lacking. In this context, there are very few studies that have compared popular HRV analysis solutions used globally. Rajalakshmi et al.[19] compared Kubios, Nevrokard and HRV Soft software tools in healthy adults using correlation and intra-class correlation coefficient (ICC) as a measure of agreement. However, we believe that ICC may not be a good statistical measure to compare bias between the tools. Therefore, we have used Bland–Altman analysis for comparison and found differences between the values reported by different software.

There are multiple strengths in the present work. Our study compares popular HRV tools that have widespread use in the scientific community. Hence, the findings have widespread applicability. We performed acquisition and analysis of artefact- and ectopic-free data by a single observer; therefore, there is little, if any, likelihood of values being affected by aberrant EGC data or interobserver bias. Based on our data, we may infer that the same data analysed by a single observer using different software tools may lead to different results, especially with reference to frequency domain parameters. We recommend that researchers looking to interpret their HRV data should look for comparable data acquired using the same software tool they are using. Comparison with HRV data acquired and processed using different software may lead to erroneous interpretation of results. This is particularly important in the context of normative data for HRV across different age and population subgroups.[48-51] Researchers looking to access and interpret these data should carefully sift through the software tool and analytical parameters defined to ensure comparability.

There are some limitations to our present work. We did not include data with artefacts and/or ectopics. Processing of such data may require deletion, interpolation or other necessary measures (‘threshold’ application in ‘K’) and therefore is likely to have a bearing on the agreement between software tools.[52-54] Another potential limitation of the present work is the use of the free-tier of ‘K’ (Kubios Scientific Lite) in the present work, which used exported RR intervals rather than raw data files for analysis. We believe this step bypasses the R wave detection process of the said software and is likely to improve concordance between the tools. Therefore, this is not a potential limitation. For Kubios Scientific Lite software, the default methodology for spectral analysis was the Welch’s periodogram. A subscription-based version of the software would have allowed us to use Lomb’s periodogram for this analytical purpose, which may have improved the agreement between the software. However, we could not obtain access to the premium version due to budget constraints.

We would like to emphasise that the present work did not intend to, nor is sufficient to, establish superiority of one software over another. We have merely compared these tools and attempted to document the differences between them. Therefore, the findings may not be construed as one software tool being better than the other two.

CONCLUSION

Notwithstanding the limitations of the present work, we may infer that frequency domain HRV indices are often different when reported by popular analytical tools. Therefore, interpretation of HRV values should be done in light of the analytical parameters used by the software solution. In addition, we recommend that researchers looking for reference values of HRV should refer to the data analysed and reported by the same platform that they intend to use for their work. We believe such an approach will ensure comparability and robustness of HRV data.

Ethical approval:

The research/study was approved by the Institutional Review Board at All India Institute of Medical Sciences Jodhpur, number AIIMS/IEC/2021/3386, dated 12th March 2021.

Declaration of patient consent:

The authors certify that they have obtained all appropriate patient consent.

Conflicts of interest:

There are no conflicts of interest.

Use of artificial intelligence (AI)-assisted technology for manuscript preparation:

The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.

Financial support and sponsorship: Nil.

References

  1. , . An overview of heart rate variability metrics and norms. Front Public Health. 2017;5:258.
    [CrossRef] [PubMed] [Google Scholar]
  2. , , , . Heart rate variability in psychology: A review of HRV indices and an analysis tutorial. Sensors (Basel). 2021;21:3998.
    [CrossRef] [PubMed] [Google Scholar]
  3. . Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task force of the European society of cardiology and the North American society of pacing and electrophysiology. Eur Heart J. 1996;17:354-81.
    [Google Scholar]
  4. , , , , , , et al. Short-term heart rate variability in healthy young adults: The cardiovascular risk in young Finns study. Auton Neurosci. 2009;145:81-8.
    [CrossRef] [PubMed] [Google Scholar]
  5. , , , , . Normative reference of short-term heart rate variability and estimation of cardiovascular autonomic neuropathy prevalence in Chinese people. J Endocrinol Invest. 2014;37:385-91.
    [CrossRef] [PubMed] [Google Scholar]
  6. , , , , , , et al. Normative values of short-term heart rate variability parameters in Koreans and their clinical value for the prediction of mortality. Heart Lung Circ. 2018;27:576-87.
    [CrossRef] [PubMed] [Google Scholar]
  7. , , , , , , et al. Normative values of short-term heart rate variability in a cross-sectional study of a Danish population. The DanFunD study. Scand J Public Health. 2024;52:48-57.
    [CrossRef] [PubMed] [Google Scholar]
  8. , , , , , , et al. Reference ranges of gender-and age-related heart rate variability parameters in Russian children. Sci Rep. 2025;15:5274.
    [CrossRef] [PubMed] [Google Scholar]
  9. , . Physical exercise and cardiac autonomic activity in healthy adult men. Indian J Physiol Pharmacol. 2014;58:365-70.
    [Google Scholar]
  10. , , , . Heart rate variability in adolescents-normative data stratified by sex and physical activity. J Clin Diagn Res. 2015;9:CC08-13.
    [CrossRef] [PubMed] [Google Scholar]
  11. , , , . Comparison of cardiovascular parameters and cardiac autonomic activity of obese and normal weight school children in puducherry. Indian J Physiol Pharmacol. 2016;60:247-54.
    [Google Scholar]
  12. , , , , , . Normative data and gender differences in heart rate variability in the healthy young individuals aged 18-30 years, a South Indian cross-sectional study. Indian Pacing Electrophysiol J. 2021;21:112-9.
    [CrossRef] [PubMed] [Google Scholar]
  13. , , , , , , et al. Heart rate variability during head-up tilt shows inter-individual differences among healthy individuals of extreme prakriti types. Physiol Rep. 2022;10:e15435.
    [CrossRef] [PubMed] [Google Scholar]
  14. , , , . Comparison between pre-prandial and post-prandial heart rate variability (HRV) Indian J Physiol Pharmacol. 2005;49:436-42.
    [Google Scholar]
  15. , , . A pilot study on short term heart rate variability & its correlation with disease activity in Indian patients with rheumatoid arthritis. Indian J Med Res. 2012;136:593-8.
    [Google Scholar]
  16. , , , , . Kubios HRV--heart rate variability analysis software. Comput Methods Programs Biomed. 2014;113:210-20.
    [CrossRef] [PubMed] [Google Scholar]
  17. , , , . Exploring ultra-short heart rate variability metrics in patients with diabetes mellitus: A reliability analysis. Int J Appl Basic Med Res. 2024;14:169-73.
    [CrossRef] [PubMed] [Google Scholar]
  18. , , . Investigating the visit-to-visit repeatability of autonomic neuropathy assessment measures in healthy subjects. Ann Neurosci 2025:9727531241310034.
    [CrossRef] [PubMed] [Google Scholar]
  19. , , . Intra-class correlation among heart rate variability analysis softwares across different physiological postures. Indian J Physiol Pharmacol. 2015;59:2-8.
    [Google Scholar]
  20. , , , . MedCalc: A new computer program for medical statistics. Comput Methods Programs Biomed. 1995;48:257-62.
    [CrossRef] [PubMed] [Google Scholar]
  21. , , , . Comparison of baroreflex responses to lower body negative pressure and valsalva maneuver in healthy subjects. Indian J Physiol Pharmacol2018;. ;62:278-85.
    [Google Scholar]
  22. , , , , , , et al. VEGF-A and cardiac autonomic function in newly diagnosed type 2 diabetes mellitus: A cross-sectional study at a tertiary care center. J Family Med Prim Care. 2019;8:3185-90.
    [CrossRef] [PubMed] [Google Scholar]
  23. , , , . Heart rate variability in myocardial infarction and heart failure. Int J Cardiol. 2007;120:289-96.
    [CrossRef] [PubMed] [Google Scholar]
  24. , , . Autonomic modulation in heart failure: Ready for prime time? Curr Cardiol Rep. 2015;17:103.
    [CrossRef] [PubMed] [Google Scholar]
  25. , , , , , , et al. Interictal heart rate variability analysis reveals lateralization of cardiac autonomic control in temporal lobe epilepsy. Front Neurol. 2020;11:842.
    [CrossRef] [PubMed] [Google Scholar]
  26. , , , , . Cardiovascular autonomic function and baroreflex sensitivity in drug-resistant temporal lobe epilepsy. Epilepsy Behav. 2023;138:109013.
    [CrossRef] [PubMed] [Google Scholar]
  27. , , , , . Minimal window duration for accurate HRV recording in athletes. Front Neurosci. 2017;11:456.
    [CrossRef] [PubMed] [Google Scholar]
  28. , , . Spectral parameters of HRV in yoga practitioners, athletes and sedentary males. Indian J Physiol Pharmacol. 2015;59:380-7.
    [Google Scholar]
  29. , , , , , , et al. How reliable are ultra-short-term HRV measurements during cognitively demanding tasks? Sensors (Basel). 2022;22:6528.
    [CrossRef] [PubMed] [Google Scholar]
  30. , , , , , , et al. Effects of missing data on heart rate variability measured from a smartwatch: Exploratory observational study. JMIR Form Res. 2025;9:e53645.
    [CrossRef] [PubMed] [Google Scholar]
  31. , , , , , , et al. Wearable devices for hemodynamic assessment in cardiovascular disease: A short literature review. Cardiol Rev 2025
    [CrossRef] [Google Scholar]
  32. , , , . Reliability of ultra-short-term analysis as a surrogate of standard 5-min analysis of heart rate variability. Telemed J E Health. 2015;21:404-14.
    [CrossRef] [PubMed] [Google Scholar]
  33. , , , , , , et al. Ultra-short-term heart rate variability during resistance exercise in the elderly. Braz J Med Biol Res. 2018;51:e6962.
    [CrossRef] [PubMed] [Google Scholar]
  34. , . A real-time QRS detection algorithm. IEEE Trans Biomed Eng. 1985;32:230-6.
    [CrossRef] [PubMed] [Google Scholar]
  35. . Methdological aspects of heart rate varibility analysis In: , , , eds. Heart rate variability (HRV) signal analysis clinical applications. Florida, USA: CRC Press, Taylor and Francis; . p. :14-20.
    [Google Scholar]
  36. , , , , , . Power spectrum analysis of heart rate fluctuation: A quantitative probe of beat-to-beat cardiovascular control. Science. 1981;213:220-2.
    [CrossRef] [PubMed] [Google Scholar]
  37. , , , , , , et al. Power spectral density of heart rate variability as an index of sympatho-vagal interaction in normal and hypertensive subjects. J Hypertens Suppl. 1984;2:S383-5.
    [Google Scholar]
  38. , , , , , , et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res. 1986;59:178-93.
    [CrossRef] [PubMed] [Google Scholar]
  39. , , , , , , et al. Heart rate variability explored in the frequency domain: A tool to investigate the link between heart and behavior. Neurosci Biobehav Rev. 2009;33:71-80.
    [CrossRef] [PubMed] [Google Scholar]
  40. , , . A healthy heart is not a metronome: An integrative review of the heart's anatomy and heart rate variability. Front Psychol. 2014;5:1040.
    [CrossRef] [PubMed] [Google Scholar]
  41. , , . A critical review of ultra-short-term heart rate variability norms research. Front Neurosci. 2020;14:594880.
    [CrossRef] [PubMed] [Google Scholar]
  42. , . Quantitative investigation of QRS detection rules using the MIT/BIH arrhythmia database. IEEE Trans Biomed Eng. 1986;33:1157-65.
    [CrossRef] [PubMed] [Google Scholar]
  43. , , . Analysis and preprocessing of HRV-kubios HRV software In: ECG time series variability analysis. United States: CRC Press; . p. :159-86.
    [CrossRef] [Google Scholar]
  44. , , . Effects of different automatic filters on the analysis of heart rate variability with kubios HRV software. Arch Med Deporte. 2017;34:196-200.
    [Google Scholar]
  45. , , , , , , et al. Impact of using different levels of threshold-based artefact correction on the quantification of heart rate variability in three independent human cohorts. J Clin Med. 2020;9:325.
    [CrossRef] [PubMed] [Google Scholar]
  46. , , . Kubios threshold-based artefact correction affects heart rate variability parameters in elite athletes. J Sci Sport Exerc. 2024;6:52-60.
    [CrossRef] [Google Scholar]
  47. , , , , , , et al. Impact of applying different levels of threshold-based artifact correction on the processing of heart rate variability data in individuals with temporomandibular disorder. Sci Rep. 2024;14:24569.
    [CrossRef] [PubMed] [Google Scholar]
  48. , , . Standardized tests of heart rate variability for autonomic function tests in healthy Koreans. Int J Neurosci. 2007;117:1707-17.
    [CrossRef] [PubMed] [Google Scholar]
  49. , , , . Normative values of resting heart rate variability in young male contact sport athletes: Reference values for the assessment and treatment of concussion. Front Sports Act Living. 2022;4:730401.
    [CrossRef] [PubMed] [Google Scholar]
  50. , , , , , , et al. Normative data on cardiovascular autonomic function in Greenlandic Inuit. BMJ Open Diabetes Res Care. 2021;9:e002121.
    [CrossRef] [PubMed] [Google Scholar]
  51. , , . Developing a five-minute normative database of heart rate variability for diagnosing cardiac autonomic dysregulation for patients with major depressive disorder. Sensors (Basel). 2024;24:4003.
    [CrossRef] [PubMed] [Google Scholar]
  52. , , . Comparison of methods for removal of ectopy in measurement of heart rate variability. Am J Physiol. 1994;267:H411-8.
    [CrossRef] [PubMed] [Google Scholar]
  53. , , . Ectopic beats in heart rate variability analysis: Effects of editing on time and frequency domain measures. Ann Noninvasive Electrocardiol. 2001;6:5-17.
    [CrossRef] [PubMed] [Google Scholar]
  54. , , , . Influence of ectopic beats on heart rate variability analysis. Entropy (Basel). 2021;23:648.
    [CrossRef] [PubMed] [Google Scholar]
Show Sections

Indian Journal of Physiology and Pharmacology

Copyright Form


Title of the Manuscript: ________________________________________


I/We certify that I/we have participated sufficiently in the intellectual content, conception, and design of this work, or the analysis and interpretation of the data (when applicable), as well as the writing of the manuscript, to take public responsibility for it. I/We agree to have my/our name(s) listed as contributors and confirm that the manuscript represents valid work.

Each author confirms they meet the criteria for authorship as established by the ICMJE. Neither this manuscript nor one with substantially similar content under my/our authorship has been published or is being considered for publication elsewhere, except as described in the covering letter.

I/We certify that all data collected during the study is presented in this manuscript and that no data from the study has been or will be published separately. I/We agree to provide, upon request by the editors, any data/information on which the manuscript is based for examination by the editors or their assignees.

I/We have disclosed all financial interests, direct or indirect, that exist or may be perceived to exist for individual contributors in connection with the content of this manuscript in the cover letter. Sources of outside support for the project are also disclosed in the cover letter.

In accordance with open access principles, I/we grant the Journal the exclusive right to publish and distribute this work under the Creative Commons Attribution-NonCommercial-ShareAlike (CC BY-NC-SA) license. This license permits others to distribute, transform, adapt, and build upon the material in any medium or format for non-commercial purposes, provided appropriate credit is given to the creator(s). Any adaptations must be shared under the same license terms. The key elements of the CC BY-NC-SA license are:

  • BY: Credit must be given to the original creator(s).
  • NC: Only non-commercial uses of the work are permitted.
  • SA: Adaptations must be shared under the same license terms.

I/We retain academic rights to the material, and the Journal is authorized to:

  1. Grant permission to republish the article in whole or in part, with or without fee.
  2. Produce preprints or reprints and translate the work into other languages for sale or free distribution.
  3. Republish the work in a collection of articles in any mechanical or electronic format.

I/We give the rights to the corresponding author to make necessary changes as requested by the Journal, handle all correspondence on our behalf, and act as the guarantor for the manuscript.

All individuals who have made substantial contributions to the work but do not meet the criteria for authorship are named in the Acknowledgment section with their written permission. If no acknowledgment is provided, it signifies that no substantial contributions were made by non-authors.


Name of the author(s) Signature Date signed Corresponding author?
Yes/No
Yes/No
Yes/No